TrialJCI insight2022

Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation.

Bhaven K Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.